tiprankstipranks
Trending News
More News >
Naya Biosciences, Inc. (NAYA)
NASDAQ:NAYA
US Market
Advertisement

NAYA Biosciences (NAYA) Stock Statistics & Valuation Metrics

Compare
155 Followers

Total Valuation

NAYA Biosciences has a market cap or net worth of $2.03M. The enterprise value is $9.82M.
Market Cap$2.03M
Enterprise Value$9.82M

Share Statistics

NAYA Biosciences has 1,066,065 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,066,065
Owned by Insiders
Owned by Institutions<0.01%

Financial Efficiency

NAYA Biosciences’s return on equity (ROE) is -0.71 and return on invested capital (ROIC) is -23.09%.
Return on Equity (ROE)-0.71
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-23.09%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee217.73K
Profits Per Employee-303.19K
Employee Count30
Asset Turnover0.14
Inventory Turnover16.64

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio0.35
Price to Fair Value0.04
Price to FCF-0.29
Price to Operating Cash Flow-0.19
PEG Ratio<0.01

Income Statement

In the last 12 months, NAYA Biosciences had revenue of 6.53M and earned -9.10M in profits. Earnings per share was -30.19.
Revenue6.53M
Gross Profit2.87M
Operating Income-8.13M
Pretax Income-9.12M
Net Income-9.10M
EBITDA-7.14M
Earnings Per Share (EPS)-30.19

Cash Flow

In the last 12 months, operating cash flow was -6.26M and capital expenditures -148.66K, giving a free cash flow of -6.41M billion.
Operating Cash Flow-6.26M
Free Cash Flow-6.41M
Free Cash Flow per Share-6.01

Dividends & Yields

NAYA Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.07
52-Week Price Change-80.45%
50-Day Moving Average
200-Day Moving Average
Relative Strength Index (RSI)
Average Volume (3m)

Important Dates

NAYA Biosciences upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

NAYA Biosciences as a current ratio of 0.07, with Debt / Equity ratio of 264.96%
Current Ratio0.07
Quick Ratio0.06
Debt to Market Cap13.40
Net Debt to EBITDA-1.28
Interest Coverage Ratio-7.69

Taxes

In the past 12 months, NAYA Biosciences has paid -22.91K in taxes.
Income Tax-22.91K
Effective Tax Rate<0.01

Enterprise Valuation

NAYA Biosciences EV to EBITDA ratio is -1.36, with an EV/FCF ratio of -3.08.
EV to Sales1.49
EV to EBITDA-1.36
EV to Free Cash Flow-3.08
EV to Operating Cash Flow-3.26

Balance Sheet

NAYA Biosciences has $840.41K in cash and marketable securities with $8.84M in debt, giving a net cash position of $8.00M billion.
Cash & Marketable Securities$840.41K
Total Debt$8.84M
Net Cash$8.00M
Net Cash Per Share$7.50
Tangible Book Value Per Share-$93.34

Margins

Gross margin is 41.57%, with operating margin of -124.40%, and net profit margin of -139.25%.
Gross Margin41.57%
Operating Margin-124.40%
Pretax Margin-139.60%
Net Profit Margin-139.25%
EBITDA Margin-109.35%
EBIT Margin-123.43%

Analyst Forecast

The average price target for NAYA Biosciences is $2.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$2.00
Price Target Upside5.26% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast390.03%
EPS Growth Forecast84.00%

Scores

Smart ScoreN/A
AI Score39
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis